This dataset explores male patients aged 40–55 who underwent elective procedures, were prescribed Ibuprofen, and recorded abnormal test results since 2023. The inclusion of Date of Admission provides a time-based perspective, which shows that even within planned (non-emergency) admissions, certain patients consistently exhibit irregular test outcomes. This suggests that standardized elective treatments may still face biological and procedural variability. To explore further, this emphasizes the need for post-procedure monitoring.
Total Patients: 4
Average Age: 49.5
Total Billing: $119,834.50
Average Billing: $29,958.62
| Name | Age | Gender | Blood Type | Condition | Admission Type | Date of Admission | Medication | Test Results | Billing ($) |
|---|---|---|---|---|---|---|---|---|---|
| chrisTiNa SChMitt | 53 | Male | B+ | Cancer | Elective | 2023-06-08 | Ibuprofen | Abnormal | 27,360.46 |
| JOdi LAnG | 44 | Male | O+ | Diabetes | Elective | 2024-03-27 | Ibuprofen | Abnormal | 22,868.53 |
| NORMAN tHoMaS | 52 | Male | A- | Cancer | Elective | 2023-05-05 | Ibuprofen | Abnormal | 33,864.95 |
| maNuEl knight | 49 | Male | A+ | Obesity | Elective | 2023-09-25 | Ibuprofen | Abnormal | 35,740.55 |